Serum level of hepcidin in cirrhotic patients as a marker for hepatocellular carcinoma

被引：0
|
作者：
Khaled Mahmoud Mohiedeen
Mona Moustafa Tahoon
Christina Samir Sadek Hanna
Mohamed Adel Abdel Aziz
机构：
[1] Alexandria University,Department of Tropical Medicine, Faculty of Medicine
[2] Alexandria University,Department of Clinical and Chemical Pathology, Faculty of Medicine
来源：
Egyptian Liver Journal | / 14卷
关键词：
Hepatocellular carcinoma (HCC); Cirrhosis; Hepcidin; Biomarker; Early detection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients
    Ahmed Alzamzamy
    Huda Elsayed
    Mona Abd Elraouf
    Hanan Eltoukhy
    Tarek Megahed
    Ashraf Aboubakr
    World Journal of Gastrointestinal Oncology, 2021, 13 (06) : 600 - 611
  • [22] SERUM CYSTATIN C LEVEL IS A GOOD PROGNOSTIC MARKER IN PATIENTS WITH CIRRHOTIC ASCITES WHEN THEIR SERUM CRETININE LEVEL IS NORMAL
    Seo, Yean Seak
    Jung, Eun Suk
    An, Hyonggin
    Keum, Bora
    Kim, Yong Sik
    Yim, Hyung Joon
    Jeen, Yoon Tae
    Chun, Hoon Jai
    Kim, Chang Duck
    Ryu, Ho Sang
    Um, Soon Ho
    HEPATOLOGY, 2008, 48 (04) : 1086A - 1086A
  • [23] Clinical significance of serum transthyretin level in patients with hepatocellular carcinoma
    Shimura, Tatsuo
    Shibata, Masahiko
    Kofunato, Yasuhide
    Okada, Ryo
    Ishigame, Teruhide
    Kimura, Takashi
    Kenjo, Akira
    Marubashi, Shigeru
    ANZ JOURNAL OF SURGERY, 2018, 88 (12) : 1328 - 1332
  • [24] Serum CA 125 as a marker of hepatocellular carcinoma
    Lopez, JB
    Balasegaram, M
    Thambyrajah, V
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1996, 11 (03): : 178 - 182
  • [25] Assessment of serum Mac-2 binding protein glycosylation isomer as a potential marker for hepatocellular carcinoma in cirrhotic hepatitis C patients
    Gamal, Mohamed
    Moheyeldin, Khaled
    Wagdy, Mona
    Aposhady, Nada
    Elkady, Aly
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 10 (02) : 90 - 97
  • [26] Identification of a new marker of hepatocellular carcinoma (HCC) by serum protein profiling of cirrhotic patients using SELDI-TOF proteinchip.
    Paradis, V
    Degos, F
    Dargere, D
    Pham, N
    Belghiti, J
    Degott, C
    Janeau, JL
    Delforge, D
    Cubizole, M
    Bedossa, P
    HEPATOLOGY, 2003, 38 (04) : 752A - 752A
  • [27] Serum testosterone: Estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients
    Tanaka, K
    Sakai, H
    Hashizume, M
    Hirohata, T
    CANCER RESEARCH, 2000, 60 (18) : 5106 - 5110
  • [28] THE SERUM TISSUE POLYPEPTIDE ANTIGEN IN THE DETECTION OF HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS
    LEANDRO, G
    ZIZZARI, S
    PICCOLI, A
    MANGHISI, OG
    HEPATO-GASTROENTEROLOGY, 1990, 37 (05) : 449 - 451
  • [29] Proteomics Analysis of Serum Samples HCV Cirrhotic Patients for Early Identification of Hepatocellular Carcinoma
    Gehrau, Ricardo
    Mas, Valeria R.
    Archer, Kellie J.
    Cotterell, Adrian H.
    Maluf, Daniel G.
    LIVER TRANSPLANTATION, 2011, 17 (06) : S108 - S108
  • [30] Serum neopterin as a marker for screening of hepatocellular carcinoma
    Tsuda, Y
    Fukuda, A
    Kobayashi, H
    Itou, D
    Yoshimoto, S
    Iwata, K
    Hanafusa, T
    PTERIDINES, 2004, 15 (04) : 161 - 169
12345